Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer

Oncoimmunology
Hye In KimTae Hyuk Kim

Abstract

Purpose: Drugs that blockade interaction between programmed cell-death protein 1 (PD-1) and its ligand (PD-L1) are promising. Immune-related adverse events (irAEs) might be associated with favorable clinical outcomes, and thyroid dysfunction is one of the most common irAE. We evaluated the association of thyroid dysfunction during PD-1 blockade with the treatment efficacy in patients with non-small cell lung cancer (NSCLC). Experimental Design: A total 58 patients with stage IV NSCLC treated with PD-1 blockade were enrolled. Patients were categorized into thyroid dysfunction and euthyroid groups. Overall survival (OS) and progression-free survival (PFS) of the two groups were compared. Patients, tumor, and medication factors were adjusted using Cox proportional hazard modeling. Objective response rate (RR) and durable control rate were assessed according to the severity of thyroid dysfunction. Results: OS [median 118.0 (73.0-267.0) vs. 71.0 (28.0-160.0) days, log-rank P = 0.025] and PFS [118.0 (73.0-267.0) vs. 61.0 (28.0-130.0), log-rank P = 0.014] were longer in the thyroid dysfunction group. After adjustment, thyroid dysfunction was an independent predictive factor for favorable outcome [adjusted HR = 0.11 (95% CI) 0.01-0.92 ...Continue Reading

References

Aug 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G Q PhanS A Rosenberg
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hansje-Eva TeulingsRosalie M Luiten
Mar 10, 2015·The Journal of Clinical Endocrinology and Metabolism·Steven OrlovPaul G Walfish
May 16, 2015·Cancer Research·Michele W L TengMark J Smyth
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Oct 9, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Morganna Freeman-KellerJeffrey Weber
Jan 1, 2016·Nature Reviews. Clinical Oncology·Egbert F Smit, Paul Baas
Jan 15, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M MichotO Lambotte
Apr 14, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J NaidooJ D Wolchok
May 3, 2016·Current Opinion in Oncology·Francesco TorinoRoberto Salvatori
Nov 5, 2016·The Journal of Clinical Endocrinology and Metabolism·Jeroen de FiletteBert Bravenboer
Oct 30, 2016·Expert Review of Anticancer Therapy·Bhumsuk KeamByung Ho Nam
Nov 15, 2016·Expert Review of Anticancer Therapy·Gautam Kishore ValechaJean Paul Atallah
Dec 29, 2016·Endocrinology and Metabolism·Duncan J Topliss
Apr 13, 2017·The New England Journal of Medicine·David J StottUNKNOWN TRUST Study Group
Jun 15, 2017·The Journal of Clinical Endocrinology and Metabolism·Danae A DelivanisMabel Ryder

❮ Previous
Next ❯

Citations

Mar 11, 2020·Thyroid : Official Journal of the American Thyroid Association·Edwin A BasakMarco Medici
Aug 19, 2020·Immunotherapy·Mary AlbrethsenJohn Nemunaitis
Apr 7, 2018·Therapeutic Advances in Medical Oncology·Aaron SosaRafael Rosell
Dec 6, 2020·Thyroid : Official Journal of the American Thyroid Association·Jacqueline JonklaasColin M Dayan
Feb 26, 2019·Cancer Immunology Research·Anne Hansen ReeGunhild M Mælandsmo
Feb 13, 2021·Cancer Immunology, Immunotherapy : CII·Li ZhongXianhe Xie
Feb 13, 2021·Journal of Endocrinological Investigation·C LuongoD Salvatore
Nov 18, 2020·Cancer Immunology, Immunotherapy : CII·Zhe ZhaoDan Zhang
Dec 15, 2020·Journal for Immunotherapy of Cancer·Aung NaingPatrick Hwu
Apr 21, 2021·The Journal of Clinical Endocrinology and Metabolism·Christopher A MuirAlexander M Menzies
Jul 17, 2021·Current Opinion in Endocrinology, Diabetes, and Obesity·Anupam Kotwal, Mabel Ryder

❮ Previous
Next ❯

Software Mentioned

SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.